Tolerability and safety of artesunate-amodiaquine and artemether- lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: Two open-label, randomized trials in Nimba County, Liberia

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Schramm, Birgit ^a   Valeh, Parastou ^a   Baudin, Elisabeth ^a   Mazinda, Charles S ^a   Smith, Richard ^a   Pinoges, Loretxu ^a   Sundaygar, Timothy ^a   Zolia, Yah M ^b   Jones, Joel J ^b   Comte, Eric ^c   Bruneel, Arnaud ^d   Branger, Michel ^d   Jullien, Vincent ^e   Carn, Gwenaelle ^f   Kiechel, Jean René ^f   Ashley, Elizabeth A ^a   Guérin, Philippe J ^a,g  

^a EPICENTRE   (France)

^b MINISTRY OF HEALTH AND SOCIAL WELFARE   (Liberia)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d BICHAT HOSPITAL   (France)

^e INSERM   (France)

^f Drugs for Neglected Diseases Initiative   (Switzerland)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Artemisinin; Liberia; Malaria; Randomized trial; Tolerability

Indexed keywords

ALANINE AMINOTRANSFERASE; AMODIAQUINE PLUS ARTESUNATE; ANTIBIOTIC AGENT; ARTEMETHER PLUS BENFLUMETOL; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; LIVER ENZYME; UNCLASSIFIED DRUG; WINTHROP; AMODIAQUINE; AMODIAQUINE, ARTESUNATE DRUG COMBINATION; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ANTIMICROBIAL THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHILD; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSTONIA; EOSINOPHIL COUNT; EOSINOPHILIA; FATIGUE; FEMALE; FEVER; FOLLOW UP; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HEPATITIS; HEPATOMEGALY; HUMAN; LEUKOCYTOSIS; LEUKOPENIA; LIBERIA; LIVER FUNCTION TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NAUSEA; NEUROTOXICITY; NEUTROPENIA; NEUTROPHIL COUNT; OPEN STUDY; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; RASH; SCHOOL CHILD; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; SPLENOMEGALY; SPONTANEOUS ABORTION; STOMATITIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VOMITING; CLINICAL TRIAL; DRUG COMBINATION; INFANT; MALARIA, FALCIPARUM; MIDDLE AGED; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84880181824     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-250     Document Type: Article

References (34)

1. Artemisinin-based combination treatment of falciparum malaria. Nosten F, White NJ, Am J Trop Med Hyg 2007 77 181 192 18165491
2. Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Senegal. Brasseur P, Agnamey P, Gaye O, Vaillant M, Taylor WR, Olliaro PL, Malar J 2007 6 150 10.1186/1475-2875-6-150 18005408 (Pubitemid 351143782)
3. Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis. Makanga M, Bassat Q, Falade CO, Premji ZG, Krudsood S, Hunt P, Walter V, Beck HP, Marrast AC, Cousin M, Rosenthal PJ, Am J Trop Med Hyg 2011 85 793 804 10.4269/ajtmh.2011.11-0069 22049029
4. The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Sirima SB, Tiono AB, Gansané A, Diarra A, Ouédraogo A, Konaté AT, Kiechel JR, Morgan CC, Olliaro PL, Taylor WR, Malar J 2009 8 48 10.1186/1475-2875-8-48 19291301
5. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Hatton CS, Peto TE, Bunch C, Pasvol G, Russell SJ, Singer CR, Edwards G, Winstanley P, Lancet 1986 1 411 414 2868340 (Pubitemid 16166282)
6. Emergency liver transplantation in amodiaquine-induced fulminant hepatitis. Markham LN, Giostra E, Hadengue A, Rossier M, Rebsamen M, Desmeules J, Am J Trop Med Hyg 2007 77 14 15 18165470 (Pubitemid 351844345)
7. Amodiaquine induced agranulocytosis and liver damage. Neftel KA, Woodtly W, Schmid M, Frick PG, Fehr J, BMJ 1986 292 721 723 10.1136/bmj.292.6522.721 3082410 (Pubitemid 16167398)
8. Amodiaquine-induced dystonic reactions: case reports and implications for policy change in Ghana. Akpalu AK Jr, Nyame PK, Dodoo ANO, Int J Risk Saf Med 2011 17 1 4
9. Dose-dependent risk of neutropenia after 7-day courses of artesunate monotherapy in Cambodian patients with acute Plasmodium falciparum malaria. Bethell D, Se Y, Lon C, Socheat D, Saunders D, Teja-Isavadharm P, Khemawoot P, Darapiseth S, Lin J, Sriwichai S, Kuntawungin W, Surasri S, Lee SJ, Sarim S, Tyner S, Smith B, Fukuda MM, Clin Infect Dis 2010 51 105 e114 10.1086/657402 21070142
10. Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria - worldwide, 2010-2012. Centers for Disease Control and Prevention (CDC), MMWR Morb Mortal Wkly Rep 2013 62 5 8 23302816
11. Randomized, multicentre assessment of the efficacy and safety of ASAQ-a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O, Malar J 2009 8 125 10.1186/1475-2875-8-125 19505304
12. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. The Four Artemisinin-Based Combinations (4ABC) Study Group, PLoS Med 2011 8 1001119 10.1371/journal.pmed.1001119 22087077
13. Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial. Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R, Pinoges L, Dhorda M, Boum Y II, Sundaygar T, Zolia YM, Jones JJ, Comte E, Houzé P, Jullien V, Carn G, Kiechel JR, Ashley EA, Guérin PJ, Malaria Journal 2013 12 251 10.1186/1475-2875-12-251 23866774
14. World Health Organization (WHO), Guidelines for the treatment of malaria 2006 Document no: WHO/HTM/MAL/2006.1108
15. Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper. Blessborn D, Romsing S, Annerberg A, Sundquist D, Bjorkman A, Lindegardh N, Bergqvist Y, J Pharm Biomed Anal 2007 45 282 287 10.1016/j.jpba.2007.07.015 17719735
16. A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma. Hodel EM, Zanolari B, Mercier T, Biollaz J, Keiser J, Olliaro P, Genton B, Decosterd LA, J Chromatogr B Analyt Technol Biomed Life Sci 2009 877 867 886 10.1016/j.jchromb.2009.02.006 19249251
17. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH harmonized tripartite guideline for good clinical practice ICH 1996 6 http://www.ich.org/fileadmin/ Public-Web-Site/ICH-Products/Guidelines/Efficacy/E6-R1/Step4/E6-R1-Guideline.pdf
18. Cancer Therapy Evaluation Program (CTEP), Common Terminology Criteria for Adverse Events (CTCAE), Version 3.0 Bethesda, US: Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), National Institute of Health (NIH), Department of Health and Human Services (DHHS) 2006
19. Division of Microbiology and Infectious Diseases, WHO toxicity grading scale for determining the severity of adverse events. Appendices: Division of Microbiology and Infectious diseases (DMID) toxicity tables: adult toxicity table May 2001; Pediatric toxicity table February 2003 Bethesda, US: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID) 2003 2 6
20. Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. McGready R, Lee S, Wiladphaingern J, Ashley E, Rijken M, Boel M, Simpson JA, Paw MK, Pimanpanarak M, Mu O, Singhasivanon P, White NJ, Nosten FH, Lancet Infect Dis 2011 12 388 396 22169409
21. Artemisinin-based combination therapy for treating uncomplicated malaria. Sinclair D, Zani B, Donegan S, Olliaro P, Garner P, Cochrane Database Syst Rev 2009 3 D007483 19588433
22. Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa. Zwang J, Ndiaye JL, Djimde A, Dorsey G, Martensson A, Karema C, Olliaro P, Malar J 2012 11 25 10.1186/1475-2875-11-25 22276858
23. Increased eosinophil activity in acute Plasmodium falciparum infection-association with cerebral malaria. Kurtzhals JA, Reimert CM, Tette E, Dunyo SK, Koram KA, Akanmori BD, Nkrumah FK, Hviid L, Clin Exp Immunol 1998 112 303 307 10.1046/j.1365-2249.1998.00586.x 9649195 (Pubitemid 28266691)
24. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Adjei GO, Kurtzhals JA, Rodrigues OP, Alifrangis M, Hoegberg LC, Kitcher ED, Badoe EV, Lamptey R, Goka BQ, Malar J 2008 7 127 10.1186/1475-2875-7-127 18620577 (Pubitemid 352033070)
25. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ, JAMA 2007 297 2210 2219 10.1001/jama.297.20.2210 17519410
26. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. Maiteki-Sebuguzi C, Jagannathan P, Yau VM, Clark TD, Njama-Meya D, Nzarubara B, Talisuna AO, Kamya MR, Rosenthal PJ, Dorsey G, Staedke SG, Malar J 2008 7 106 10.1186/1475-2875-7- 106 18547415 (Pubitemid 351904896)
27. Drug interactions involving combination antiretroviral therapy and other anti-infective agents: repercussions for resource-limited countries. Dooley KE, Flexner C, Andrade AS, J Infect Dis 2008 198 948 961 10.1086/591459 18713054
28. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango JN, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal PJ, Havlir D, Dorsey G, Clin Infect Dis 2008 46 985 991 10.1086/529192 18444813 (Pubitemid 351589861)
29. Joint United Nations Programme on HIV/AIDS (UNAIDS), UNAIDS Report on the global AIDS Epidemic 2012 Geneva: UNAIDS 2012 Document no: UNAIDS/JC2417E
30. Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast. Faye B, Offianan AT, Ndiaye JL, Tine RC, Toure W, Djoman K, Sylla K, Ndiaye PS, Penali L, Gaye O, Trop Med Int Health 2010 15 608 613 20214761
31. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Ndiaye JL, Faye B, Gueye A, Tine R, Ndiaye D, Tchania C, Ndiaye I, Barry A, Cissé B, Lameyre V, Gaye O, Malar J 2011 10 237 10.1186/1475-2875-10-237 21838909
32. Bioavailability of a co-formulated combination of amodiaquine and artesunate under fed and fasted conditions. A randomised, open-label crossover study. Fitoussi S, Thang C, Lesauvage E, Barre J, Charron B, Filali-Ansary A, Lameyre V, Arzneimittelforschung 2009 59 370 376 19728565
33. Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda. Staedke SG, Jagannathan P, Yeka A, Bukirwa H, Banek K, Maiteki-Sebuguzi C, Clark TD, Nzarubara B, Njama-Meya D, Mpimbaza A, Rosenthal PJ, Kamya MR, Wabwire-Mangen F, Dorsey G, Talisuna AO, Malar J 2008 7 107 10.1186/1475-2875-7-107 18547416 (Pubitemid 352000602)
34. Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa. Zwang J, Dorsey G, Djimde A, Karema C, Martensson A, Ndiaye JL, Sirima SB, Olliaro P, Malar J 2012 11 260 10.1186/1475-2875-11-260 22856598